Greed Pays Off for Eli Lilly
Posted on November 15, 2021 |
By 340B Matters The drug industry already has some of the highest profit margins of any sector and they’re getting higher for Eli Lilly. U.S. revenues increased by a whopping 26% ...
Posted on November 15, 2021 |
By 340B Matters The drug industry already has some of the highest profit margins of any sector and they’re getting higher for Eli Lilly. U.S. revenues increased by a whopping 26% ...
Posted on October 19, 2021 |
By 340B Matters If there were any doubts about just how idiotic Big Pharma’s arguments can be against the 340B Drug Discount Program, look no further than Arkansas where the ...
Posted on October 01, 2021 |
By 340B Matters The Department of Health and Human Services has referred six recalcitrant drug companies to the agency Inspector General for civil monetary penalties for denying 340B discounts to healthcare ...
Posted on September 08, 2021 |
By 340B Matters Dear Secretary Becerra, On August 1 and September 1, Boehringer Ingelheim and Merck respectively began denying 340B discount pricing to safety-net healthcare providers that use contract pharmacies. This is ...
Posted on August 17, 2021 |
By 340B Matters At long last, four top pharmaceutical companies are being sued under federal antitrust law for conspiring to deprive safety-net healthcare providers of lower pricing under the 340B Drug ...